With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease treatments, we are talking about treating meibomian gland dysfunction and evaporative dry eye.For decades, meibomian gland dysfunction …
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today the c…
Finding ways that AI best fits into clinical practice while learning how accurate and useful it can be, especially for patients, could help clinicians trust it more in their daily workflow.“I do think that AI in health care has a long way to go to be t…
HELSINKI — Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed cataract suggested good safety, high tolerability and reversibility for the implant.At the European Society of Catara…
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press release from Aldeyra Therapeutics.According to A…
‘Restricting teens’ access to indoor tanning and informing the public about the dangers of indoor tanning are critical to preventing skin cancer,’ AAD President Susan C. Taylor, MD, said. Medscape Medical News